Form 4: Praxis Precision Medicines Executive Nemiroff Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Alex Nemiroff, General Counsel and Secretary of Praxis Precision Medicines, reports disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 12, 2025, Alex Nemiroff, the General Counsel and Secretary of Praxis Precision Medicines, Inc., disposed of 51 shares of common stock.
- The shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of previously reported restricted stock units.
- The transaction was executed at a price of $85.4 per share.
- Following the transaction, Nemiroff directly owns 20,831.667 shares of Praxis Precision Medicines, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax obligations, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of stock disposal transaction. |
| 02/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.